RAYBUFAN Trademark

Trademark Overview

On Wednesday, February 13, 2013, a trademark application was filed for RAYBUFAN with the United States Patent and Trademark Office. The USPTO has given the RAYBUFAN trademark a serial number of 85849361. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 3, 2016. This trademark is owned by Braeburn Pharmaceuticals BVBA SPRL. The RAYBUFAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
raybufan

General Information

Serial Number85849361
Word MarkRAYBUFAN
Filing DateWednesday, February 13, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 3, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2013

Trademark Statements

Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 21, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBraeburn Pharmaceuticals BVBA SPRL
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address1190 Vorst
BE
Party NameBraeburn Pharmaceuticals BVBA SPRL
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1190 Vorst
BE

Trademark Events

Event DateEvent Description
Monday, October 3, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 3, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, September 2, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 16, 2016TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, February 4, 2016EXTENSION 5 GRANTED
Wednesday, February 3, 2016EXTENSION 5 FILED
Wednesday, February 3, 2016TEAS EXTENSION RECEIVED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, August 5, 2015EXTENSION 4 GRANTED
Tuesday, August 4, 2015EXTENSION 4 FILED
Tuesday, August 4, 2015TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Saturday, January 24, 2015EXTENSION 3 GRANTED
Thursday, January 22, 2015EXTENSION 3 FILED
Thursday, January 22, 2015TEAS EXTENSION RECEIVED
Wednesday, September 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, September 9, 2014EXTENSION 2 GRANTED
Monday, August 25, 2014EXTENSION 2 FILED
Tuesday, September 9, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 25, 2014TEAS EXTENSION RECEIVED
Thursday, February 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 25, 2014EXTENSION 1 GRANTED
Tuesday, February 25, 2014EXTENSION 1 FILED
Tuesday, February 25, 2014TEAS EXTENSION RECEIVED
Tuesday, August 27, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2013NOTICE OF PUBLICATION
Wednesday, May 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2013ASSIGNED TO EXAMINER
Thursday, February 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

raybufan system formulation matrix pharmaceuticals release treatment drugs based sustained implantable